NCT00572806已完成4 期
Evaluation of the Initiation of Insulin Treatment Using Insulin Aspart on Blood Glucose Profile in Type 2 Diabetes Mellitus
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 6
- 试验地点
- 2
- 主要终点
- Blood glucose value
研究概览
简要总结
This trial is conducted in Europe. The aim of this trial is to investigate if using insulin aspart as start therapy will improve the efficacy on daytime blood glucose cycle profile in subjects with type 2 diabetes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes for at least 3 years
- •HbA1c greater than 8.0%
- •Body Mass Index (BMI) below 40.0 kg/m2
- •Inadequate treatment with diet and OADs
- •Never received treatment with insulin
排除标准
- •Type 1 diabetes
- •Known or suspected allergy to investigational product
结局指标
主要结局
Blood glucose value
时间窗: at 5 pm in a daytime blood glucose cycle profile
次要结局
- HbA1c
- Hypoglycaemic episodes
- Evaluation of 24-hour blood glucose cycle
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesDiabetesDiabetes Mellitus, Type 1NCT00571935Novo Nordisk A/S61
已完成
4 期
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesDiabetes Mellitus, Type 2DiabetesNCT00274274Novo Nordisk A/S373
已完成
不适用
Physiological Concept of Insulin Therapy in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01536639Novo Nordisk A/S454
已完成
3 期
Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT00605020Novo Nordisk A/S719
已完成
1 期
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusDiabetesDiabetes Mellitus, Type 2NCT02933853Novo Nordisk A/S61